Bortezomib in Combination With CC-5013 in Patients With Relapsed/Refractory Multiple Myeloma
Clinical trial NCT00153933 · COMPLETED
Trial details
- NCT number
- NCT00153933
- Sponsor
- Dana-Farber Cancer Institute
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2004-08-01
- Primary completion
- 2014-07-01
- Enrollment
- 58
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.